These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 19920354)

  • 21. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts.
    Park JE; Lenter MC; Zimmermann RN; Garin-Chesa P; Old LJ; Rettig WJ
    J Biol Chem; 1999 Dec; 274(51):36505-12. PubMed ID: 10593948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
    Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
    Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma.
    Wong PF; Gall MG; Bachovchin WW; McCaughan GW; Keane FM; Gorrell MD
    Peptides; 2016 Jan; 75():80-95. PubMed ID: 26621486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice.
    Duperret EK; Trautz A; Ammons D; Perales-Puchalt A; Wise MC; Yan J; Reed C; Weiner DB
    Clin Cancer Res; 2018 Mar; 24(5):1190-1201. PubMed ID: 29269377
    [No Abstract]   [Full Text] [Related]  

  • 26. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice.
    Fang J; Xiao L; Joo KI; Liu Y; Zhang C; Liu S; Conti PS; Li Z; Wang P
    Int J Cancer; 2016 Feb; 138(4):1013-23. PubMed ID: 26334777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
    Cremasco V; Astarita JL; Grauel AL; Keerthivasan S; MacIsaac K; Woodruff MC; Wu M; Spel L; Santoro S; Amoozgar Z; Laszewski T; Migoni SC; Knoblich K; Fletcher AL; LaFleur M; Wucherpfennig KW; Pure E; Dranoff G; Carroll MC; Turley SJ
    Cancer Immunol Res; 2018 Dec; 6(12):1472-1485. PubMed ID: 30266714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein.
    Dvořáková P; Bušek P; Knedlík T; Schimer J; Etrych T; Kostka L; Stollinová Šromová L; Šubr V; Šácha P; Šedo A; Konvalinka J
    J Med Chem; 2017 Oct; 60(20):8385-8393. PubMed ID: 28953383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens.
    Zhang J; Valianou M; Simmons H; Robinson MK; Lee HO; Mullins SR; Marasco WA; Adams GP; Weiner LM; Cheng JD
    FASEB J; 2013 Feb; 27(2):581-9. PubMed ID: 23104982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting fibroblast activation protein in cancer - Prospects and caveats.
    Busek P; Mateu R; Zubal M; Kotackova L; Sedo A
    Front Biosci (Landmark Ed); 2018 Jun; 23(10):1933-1968. PubMed ID: 29772538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice.
    Panaro BL; Coppage AL; Beaudry JL; Varin EM; Kaur K; Lai JH; Wu W; Liu Y; Bachovchin WW; Drucker DJ
    Mol Metab; 2019 Jan; 19():65-74. PubMed ID: 30477988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of fibroblast activation protein in patients with colon cancer.
    Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
    Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth.
    Cheng JD; Valianou M; Canutescu AA; Jaffe EK; Lee HO; Wang H; Lai JH; Bachovchin WW; Weiner LM
    Mol Cancer Ther; 2005 Mar; 4(3):351-60. PubMed ID: 15767544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
    LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
    Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
    Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
    Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast activation protein is dispensable in the anti-influenza immune response in mice.
    Tan SY; Chowdhury S; Polak N; Gorrell MD; Weninger W
    PLoS One; 2017; 12(2):e0171194. PubMed ID: 28158223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seprase: an overview of an important matrix serine protease.
    O'Brien P; O'Connor BF
    Biochim Biophys Acta; 2008 Sep; 1784(9):1130-45. PubMed ID: 18262497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse fibroblast-activation protein--conserved Fap gene organization and biochemical function as a serine protease.
    Niedermeyer J; Enenkel B; Park JE; Lenter M; Rettig WJ; Damm K; Schnapp A
    Eur J Biochem; 1998 Jun; 254(3):650-4. PubMed ID: 9688278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
    Huber MA; Kraut N; Park JE; Schubert RD; Rettig WJ; Peter RU; Garin-Chesa P
    J Invest Dermatol; 2003 Feb; 120(2):182-8. PubMed ID: 12542520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia.
    Tran E; Chinnasamy D; Yu Z; Morgan RA; Lee CC; Restifo NP; Rosenberg SA
    J Exp Med; 2013 Jun; 210(6):1125-35. PubMed ID: 23712432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.